FNY Investment Advisers, LLC

Position in ILMN — Illumina, Inc.

CIK 1742998 NEW YORK, NY

Position in ILMN

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$114,289

+$52,659 QoQ

Shares Held

650

+30.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#48

of 81 holders

Holding Since

Sep 2022

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

FNY Investment Advisers, LLC holds $1,326,321 across 4 Diagnostics & Research names. ILMN ranks #2 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IMDX	Insight Molecular Diagnostics Inc.	182,561	$1,077,109
2	ILMN	Illumina, Inc. This page	650	$114,289
3	TMO	Thermo Fisher Scientific Inc.	150	$75,204
4	NTRA	Natera, Inc.	220	$59,719

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$114,289	650	+30.0%	Shares	Defined	2026-07-08
2026-03-31	$61,630	500	0.0%	Shares	Sole	2026-04-15
2025-12-31	$65,580	500	-50.0%	Shares	Sole	2026-01-16
2025-09-30	$95,064	1,001	-71.9%	Shares	Defined	2025-12-15
2024-06-30	$371,279	3,557	+137.1%	Shares	Sole	2024-08-05
2023-09-30	$200,311	1,500	+638.9%	Shares	Defined	2023-10-10
2023-03-31	$45,921	203	-22.8%	Shares	Defined	2023-04-12
2022-09-30	$48,811	263	—	Shares	Defined	2022-10-19
No filing history on record for this holder in this stock.